CURANUM AG

EANS-Adhoc: CURANUM AG
Financial Figures 2009

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

31.03.2010

Ad hoc announcement

CURANUM AG publishes 2009 results

Occupancy stable in 2009, revenue and EBITDA budgets achieved

CURANUM AG, Munich, announces  its  results  for  the  2009   financial  year  at today's results press conference and analyst meeting in Frankfurt. The  capacity utilization of care beds and managed apartments was stable in 2009, albeit at  a somewhat lower average level than in 2008.

Revenue rose by 1.0% from EUR 257.1 million in  2008  to  EUR 259.5   million  in 2009, an increase of EUR 2.4 million. We thereby   exceeded  our  revenue  budget (EUR 257.0 million to EUR 259.0 million). The increase was due to  revenue  from our new Scheffelhof senior  residence  in  Bad  Dürrheim,  the  senior  citizen residence and care facility in Braunschweig,  as  well  as  additional   revenues from our outpatient service in Coburg, and  from  care   services  for  occupants suffering dementia.

Rental expenses rose by EUR 0.9 million or 1.65% to EUR 55.5  million (previous year: EUR 54.6 million). This was mainly due to the rental indexations  of  the properties we rent. Staff costs increased  by   EUR 2.7  million  or  2.1%,  from EUR 127.8 million in 2008 to EUR 130.5 million in 2009.

As a consequence, earnings before interest, tax, depreciation, amortization  and rents (EBITDAR) amounted to EUR 83.1 million in 2009  (previous  year:  EUR 83.9 million), reflecting a decline of EUR 0.8 million  or  0.95%  year-on-year.  The EBITDAR margin stood at 32.0% (previous year: 32.6%), which  represents  a  peak outcome on a European peer group comparison.

EBITDA earnings declined from EUR 29.3 million in 2008 to  EUR 27.6   million  in 2009, which corresponds to an EBITDA margin of 10.64% in this  reporting  period (previous year: 11.4%).

Compared with  the  previous  year,  depreciation  and  amortization rose  only slightly from EUR 9.5 million in 2008 to EUR 9.8 million in  2009,  representing an increase of EUR 0.3 million or  3.16%.  As a  consequence,  earnings  before interest and tax (EBIT) amounted to EUR 17.8 million  (previous  year:  EUR 19.7 million), reflecting an EBIT margin of 6.86% in 2009 (previous year: 7.66%).

The tax rate increased in 2009. Consequently, income tax and deferred tax  were around EUR 0.7 million higher than budgeted. At EUR 5.8 million (previous  year: EUR 7.0 million) we failed to achieve our budgeted post-tax earnings of  EUR 6.5 million - EUR 8.5 million. Earnings per share amounted to EUR 0.18 in  the  2009 reporting period (previous year: EUR 0.22).

Cash flow from operating activities  rose  slightly  from  EUR 19.8   million  to EUR 19.9 million as of the end of 2009, and  the  cash   outflow  from  investing activities dropped from EUR 18.7 million to EUR 5.2 million in 2009.  Cash  flow from  financing  activities  was again  characterized  by  the  redemption    of financial liabilities in an amount of EUR 5.6 million  (previous  year:  EUR 4.9 million), outgoing payments for finance leasing  of  EUR 7.8  million   (previous year: EUR 7.6 million), as well as the dividend payment at the  previous  year's level at EUR 3.2 million.

The full results for the 2009 financial year are available  on  our   website  at www.curanum.de in the Investor Relations area.

Munich, March 31, 2010

The Management Board

@@start.t2@@|Key figures IFRS as of December 31,      |                 |                         |
|2009                                                        |                 |                         |
|                                                 |          |                 |                         |
|                                                 |          |                 |                         |
|mil.  EUR                                  |2009    |2008 1)      |YOY in %            |
|                                                 |          |                 |                         |
|Sales                                         |259.5  |257.1         |0.93                  |
|Staff costs                                |130.5  |127.8         |2.11                  |
|EBITDAR                                      |83.1    |83.9          |-0.95                 |
|Rental costs                              |55.5    |54.6          |1.65                  |
|EBITDA                                        |27.6    |29.3          |-5.80                 |
|in % of Sales                            |10.6%  |11.4%         |                         |
|Depreciation                              |9.8      |9.5            |3.16                  |
|EBIT                                          |17.8    |19.7          |-9.64                 |
|in % of Sales                            |6.9%    |7.7%          |                         |
|Financial results                      |-8.9    |-9.5          |-6.32                 |
|EBT                                            |8.9      |10.2          |-12.75                |
|Net profit                                 |5.8      |7.0            |-17.14                |
|EPS (EUR) *)                              |0.18    |0.22          |-18.18                |
|                                                 |          |                 |                         |
|Cashflow                                    |19.9    |19.8          |0.51                  |
|CPS (EUR) *)                              |0.62    |0.61          |1.64                  |
|                                                 |          |                 |                         |
|Cash and cash equivalents         |8.9      |10.0          |-11.00                |
|Equity capital                          |66.1    |64.1          |3.12                  |
|in % of balance sheet total      |28.0%  |27.0%         |                         |
|Balance sheet total                  |236.4  |237.7         |-0.55                 |
|                                                 |          |                 |                         |
|Employees                                  |6,055  |5,953         |1.71                  |
|Facilities                                 |69        |68              |1.47                  |
|Care places                                |7,805  |7,708         |1.26                  |
|Assisted living apartements      |1,681  |1,638         |2.63                  |
|                                                 |          |                 |                         |
|*) Number of unterlying outstanding      |                 |                         |
|shares in 2009: 32,267,835 shares         |                 |                         |
|*) Number of underlying outstanding      |                 |                         |
|shares in 2008: 32,611,091 shares         |                 |                         |
|1) restated in 2009                                |                 |                         |@@end@@

@@start.t3@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marion Mühlschlegel

Tel.  +49 (0)89 242065-68

Email marion.muehlschlegel@curanum.de

Branche: Healthcare Providers
ISIN:      DE0005240709
WKN:        524070
Index:    SDAX, CDAX, Classic All Share, Prime All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / regulated dealing



Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: